1
/
of
0
FDA Drug Approval, N019350, CUPRIC SULFATE
FDA Drug Approval, N019350, CUPRIC SULFATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019350
Company: ABRAXIS PHARM
Drug Name: CUPRIC SULFATE
Active Ingredients: CUPRIC SULFATE
Strength: EQ 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 05/05/1987
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: ABRAXIS PHARM
Drug Name: CUPRIC SULFATE
Active Ingredients: CUPRIC SULFATE
Strength: EQ 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 05/05/1987
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details